Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Glucose-6-phosphate dehydrogenase, Headache, Hyperhidrosis
Clinical narrative: severe sweats; head aches; body aches; fever; chills; extremely tired; This spontaneous case was reported by an other and describes the occurrence of HYPERHIDROSIS (severe sweats), HEADACHE (head aches), MYALGIA (body aches), PYREXIA (fever) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.     On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (severe sweats), HEADACHE (head aches), MYALGIA (body aches), PYREXIA (fever), CHILLS (chills) and FATIGUE (extremely tired). At the time of the report, HYPERHIDROSIS (severe sweats), HEADACHE (head aches), MYALGIA (body aches), PYREXIA (fever), CHILLS (chills) and FATIGUE (extremely tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Glucose-6-phosphate dehydrogenase: normal (normal) not G6PD deficient..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  No treatment medication was reported by reporter.    Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Pfizer report : dose number changed to 2nd dose This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Jun-2021 and was forwarded to Moderna on 21-Jun-2021.    This spontaneous case was reported by an other and describes the occurrence of HYPERHIDROSIS (severe sweats), HEADACHE (head aches), MYALGIA (body aches), PYREXIA (fever) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.     On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (severe sweats), HEADACHE (head aches), MYALGIA (body aches), PYREXIA (fever), CHILLS (chills) and FATIGUE (extremely tired). At the time of the report, HYPERHIDROSIS (severe sweats), HEADACHE (head aches), MYALGIA (body aches), PYREXIA (fever), CHILLS (chills) and FATIGUE (extremely tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Glucose-6-phosphate dehydrogenase: normal (normal) not G6PD deficient..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  No treatment medication was reported by reporter.    Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Pfizer report : dose number changed to 2nd dose